Results 211 to 220 of about 180,829 (383)

CD20; CD47 [PDF]

Science-Business eXchange, 2010
openaire   +1 more source

Possible role of CD22, CD79b and CD20 expression in distinguishing small lymphocytic lymphoma from chronic lymphocytic leukemia [PDF]

, 2014
Danijela Jovanović, Predrag Djurdjević, Nebojša Andjelković, Ljubica Živić   +3 more
openalex   +1 more source

Supplementary Materials and Methods, Supplementary Figure Legends, and Supplementary Table S1 from T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells

, 2023
Eugenia Zah, Meng‐Yin Lin, Anne Silva-Benedict, Michael C. Jensen, Yvonne Y. Chen   +4 more
openalex   +1 more source

Anti-CD20 Monoclonal Antibody B001 [PDF]

, 2020
National Cancer Institute
openalex   +1 more source

Bruton tyrosine kinase (Btk) in neutrophils is indispensable for initiating and maintaining skin inflammation in a model of pemphigoid diseases

British Journal of Pharmacology, EarlyView.
Background and Purpose Bruton tyrosine kinase (Btk) is essential for B cell function. Its role in myeloid cells is less understood. Greater insights into Btk significance in myeloid cells are needed to evaluate its potential as a therapeutic target during the effector phase of antibody‐induced autoimmune diseases, where inhibiting autoantibody ...
Henning Olbrich, Paul Schilf, Sripriya Murthy, Sina Gonther, Mareike Neumann, Christoph M. Hammers, Jasper N. Pruessmann, Christian D. Sadik   +7 more
wiley   +1 more source

CD20 Negative [PDF]

, 2020
openaire   +1 more source

Supplementary Figures S1 to S7 from Rational Protein Design Yields a CD20 CAR with Superior Antitumor Efficacy Compared with CD19 CAR

, 2023
Ximin Chen, Laurence C. Chen, Mobina Khericha, Xiangzhi Meng, Emma Salvestrini, Amanda Shafer, Neha Iyer, Anya S. Alag, Yunfeng Ding, Demetri M. Nicolaou, Yvonne Y. Chen   +10 more
openalex   +2 more sources

Tafasitamab as Monotherapy or in Combination in Japanese Patients With B‐Cell Non‐Hodgkin Lymphoma: Results From the Phase 1b J‐MIND Study

Cancer Science, EarlyView.
J‐MIND evaluated the safety and tolerability of tafasitamab, a CD19‐targeting monoclonal antibody, alone or in combination with other therapies in Japanese patients with B‐cell non‐Hodgkin lymphoma (NHL). Most common treatment‐emergent adverse events across all groups were hematological, and no serious tafasitamab treatment‐related or fatal adverse ...
Koji Izutsu, Noriko Fukuhara, Junichiro Yuda, Youko Suehiro, Shigeru Kusumoto, Marie‐Laure Casadebaig, Kazumi Suzukawa, Kentaro Fukushima   +7 more
wiley   +1 more source

CD20 Positive [PDF]

, 2020
openaire   +1 more source

Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene.

Blood, 2002
G. Cartron, L. Dacheux, G. Salles, P. Solal-Céligny, P. Bardos, P. Colombat, H. Watier   +6 more
semanticscholar   +1 more source